|
|
 |
 |
| The International Myeloma Workshop, held every two years, provides new insights into the origins and progression of multiple myeloma and innovative new approaches for treatment. Click on any of the following programs to listen to these world renowned myeloma experts summarize the Workshop's daily highlights. This unique online program also features abstracts from each of the Workshop's scientific sessions. |
 |
 |
 |
|
 |
|
|
|
|
 |
Arsenic Trioxide in Multiple Myeloma: Rationale and Future Directions
Mohamad Hussein, MD
The Cleveland Clinic,
Click here for abstracts, transcripts, and slides.
|
|
|
|
| |
Novel Therapeutic Approaches in the Treatment of Multiple Myeloma:
Targeting the Bone Microenvironment
James Berenson, MD
Cedars-Sinai Medical Center,
Click here for abstracts, transcripts, and slides.
|
|
|
|
| |
MMRF Cell-Signaling Roundtable
William Dalton, MD, PhD
H. Lee Moffitt Cancer Center,
Click here for abstracts, transcripts, and slides.
|
|
|
|
| |
The Malignant Clone in Myeloma
Linda Pilarski, MD
University of Alberta Cross Cancer Institute, CANADA,
Click here for abstracts, transcripts, and slides.
|
|
|
|
| |
Innovative Technologies
Keith Stewart, MD
Princess Margaret Hospital, CANADA,
Click here for abstracts, transcripts, and slides.
|
|
|
|
| |
Angiogenesis
Vincent Rajkumar, MD
Mayo Clinic,
Click here for abstracts, transcripts, and slides.
|
|
|
|
| |
Allogeneic and Autologous Transplantation
William Bensinger, MD
Fred Hutchinson Cancer Center,
Click here for abstracts, transcripts, and slides.
|
|
|
|
| |
New Therapies
Kenneth Anderson, MD
Dana-Farber Cancer Institute,
Click here for abstracts, transcripts, and slides.
|
|
|
|
| |
Treatment Modalities and Symptom Management
Philip Greipp, MD
Mayo Clinic,
Click here for abstracts, transcripts, and slides.
|
|
|
|
| |
Signaling and Microenvironment
Regis Bataille, MD, PhD
Institute of Biology, FRANCE,
Click here for abstracts, transcripts, and slides.
|
|
|
|
| |
Genetic Instability and Oncogenesis
John Shaughnessy, Jr., MD
Arkansas Cancer Research Center,
Click here for abstracts, transcripts, and slides.
|
|
|
|
| |
Oncogenic Events
Michael Kuehl, MD
National Cancer Institute,
Click here for abstracts, transcripts, and slides.
|
|
|
|
| |
Immunotherapies and Control of Residual Disease
Steven Treon, MD
Dana-Farber Cancer Institute,
Click here for abstracts, transcripts, and slides.
|
|
|
|
| |
Vaccine Strategies
Freda Stevenson, Dphil FRCPath
University of Southampton, ENGLAND,
Click here for abstracts, transcripts, and slides.
|
|
|
|
| |
Bone Metabolism, Bone Disease and Bisphosphonates
Jonathan R. Green, PhD
Novartis Oncology,
Click here for abstracts, transcripts, and slides.
|
|
|
|
| |
Thalidomide: Mechanisms of Action and Clinical Outcomes
Kenneth Anderson, MD
Dana-Farber Cancer Institute,
Click here for abstracts, transcripts, and slides.
|
|
|
|
| |
Thalidomide: Mechanisms of Action and Clinical Outcomes
Bart Barlogie, MD
Arkansas Cancer Research Center, Little Rock, Arkansas,
Click here for abstracts, transcripts, and slides.
|
|
|
|
| |
Clinical Implications
Bart Barlogie, MD
Arkansas Cancer Research Center, Little Rock, Arkansas,
Click here for abstracts, transcripts, and slides.
|
|
|
|
|
Back to top
|
|
System Requirements
This Web site takes advantage of the latest Internet technology to bring you the most cutting-edge information on cancer.
The MedClip Lectures require the RealOne Player or later version for audio/video. We recommend you install the latest version of the free plug-in before viewing the MedClipsTM.
|
|
|
|
| | |
